IDO1 and infection: Additional analyses of the data on secondary endpoints, including measurements of mononuclear cells, serum cytokines, and other serum/plasma defined inflammatory/infection indicators will delineate local and systemic immune responses to the M032 virus, progression-free survival, overall survival alone and with IDO inhibition.